Skip to main content
See every side of every news story
Published loading...Updated

Trump Wants to Overhaul Drug Sales. A Company Tied to His Son Stands to Benefit

Summary by Seeking Alpha
Family members of President Donald Trump and Commerce Secretary Howard Lutnick are set to profit from the U.S. government's pharma overhaul. Read more here.

5 Articles

El PeriódicoEl Periódico
+2 Reposted by 2 other sources

Trump is studying a drug sales reform that would favor a company linked to his first-born son, according to the newspaper 'The Wall Street Journal'. The country's leading drug manufacturers will meet in early December at the Four Seasons Hotel in Georgetown with Donald Trump Jr. and senior officials of the Trump Administration who regulate the pharmaceutical industry, reports the U.S. newspaper.Continue reading....

·Barcelona, Spain
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Wall Street Journal broke the news in New York, United States on Wednesday, October 8, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal